122 related articles for article (PubMed ID: 15162546)
1. Expression of subtypes of somatostatin receptors in hepatic stellate cells.
Song SH; Leng XS; Li T; Qin ZZ; Peng JR; Zhao L; Wei YH; Yu X
World J Gastroenterol; 2004 Jun; 10(11):1663-5. PubMed ID: 15162546
[TBL] [Abstract][Full Text] [Related]
2. [The effect of somatostatin analogue on expression of connective tissue growth factor gene of rat hepatic stellate cells].
Song SH; Leng XS; Li T; Peng JR; Zhao L; Qin ZZ; Wei YH; Yu X
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):551-3. PubMed ID: 15196370
[TBL] [Abstract][Full Text] [Related]
3. Relationship between somatostatin receptors and activation of hepatic stellate cells.
Pan Q; Li DG; Lu HM; Lu LY; You HN; Xu QF
Chin Med J (Engl); 2004 Nov; 117(11):1665-9. PubMed ID: 15569483
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor 1-5; expression profiles during rat development.
Ludvigsen E; Carlsson C; Tiensuu Janson E; Sandler S; Stridsberg M
Ups J Med Sci; 2015; 120(3):157-68. PubMed ID: 25926390
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.
Casarini AP; Jallad RS; Pinto EM; Soares IC; Nonogaki S; Giannella-Neto D; Musolino NR; Alves VA; Bronstein MD
Pituitary; 2009; 12(4):297-303. PubMed ID: 19330452
[TBL] [Abstract][Full Text] [Related]
7. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
8. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
[TBL] [Abstract][Full Text] [Related]
9. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.
Reynaert H; Rombouts K; Vandermonde A; Urbain D; Kumar U; Bioulac-Sage P; Pinzani M; Rosenbaum J; Geerts A
Gut; 2004 Aug; 53(8):1180-9. PubMed ID: 15247189
[TBL] [Abstract][Full Text] [Related]
10. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.
Klironomos S; Notas G; Sfakianaki O; Kiagiadaki F; Xidakis C; Kouroumalis E
Regul Pept; 2014 Jan; 188():5-12. PubMed ID: 24291170
[TBL] [Abstract][Full Text] [Related]
11. Distribution and functional significance of somatostatin receptors in malignant melanoma.
Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
[TBL] [Abstract][Full Text] [Related]
12. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR.
Taboada GF; Luque RM; Neto LV; Machado Ede O; Sbaffi BC; Domingues RC; Marcondes JB; Chimelli LM; Fontes R; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
Eur J Endocrinol; 2008 Mar; 158(3):295-303. PubMed ID: 18299461
[TBL] [Abstract][Full Text] [Related]
15. Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum.
Bai J; Liu X; Le Goff L; Gargala G; François A; Ballet JJ; Ducrotte P; Favennec L; Towledahong L
PLoS One; 2018; 13(3):e0194058. PubMed ID: 29522573
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1.
Reynaert H; Vaeyens F; Qin H; Hellemans K; Chatterjee N; Winand D; Quartier E; Schuit F; Urbain D; Kumar U; Patel YC; Geerts A
Gastroenterology; 2001 Oct; 121(4):915-30. PubMed ID: 11606505
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
Taboada GF; Luque RM; Bastos W; Guimarães RF; Marcondes JB; Chimelli LM; Fontes R; Mata PJ; Filho PN; Carvalho DP; Kineman RD; Gadelha MR
Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.
Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ
Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
[TBL] [Abstract][Full Text] [Related]
20. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
